Kura Oncology, Inc. ( KURA) - Key Metrics
KURA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.23 | -$0.77 | -$0.70 | -$0.71 |
| 2026Q1 | $0.21 | -$0.83 | -$0.97 | -$0.97 |
| 2025Q4 | $0.20 | -$0.92 | $1.33 | $1.31 |
| 2025Q3 | $0.24 | -$0.85 | -$0.92 | -$0.95 |
| 2025Q2 | $0.17 | -$0.75 | -$0.33 | -$0.35 |
KURA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.56 |
| 2026Q1 | 0% | -2.45 |
| 2025Q4 | 0% | -2.82 |
| 2025Q3 | 0% | -2.60 |
| 2025Q2 | 0% | -1.92 |
KURA
Price: $10.86
52 week price:
Earnings Per Share: -3.42 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 495600
Ebitda: -9.1 millionMarket Capitalization: 897.6 million